Financial Info

Financial Highlights  |  Ratios

Valuation P/E 14.07x   P/S 2.53x   P/B 3.12x   EPS 7243.15	Financial Strength Quick Ratio (MRQ) 2.07x   Current Ratio (MRQ) 2.82x   Total Debt/Equity (MRQ) 0.40x   Total Debt/Assets (MRQ) 0.29x	Operating Ratios Assets Turnover (TTM) 0.84x   Inventory Turnover (TTM) 2.07x   Receivables Turnover (TTM) 8.51x
Profitability Gross Margin (TTM) 47.77%   Operating Margin (TTM) 22.80%   EBIT Margin (TTM) 21.43%   Profit Margin (TTM) 18.48%	Management Effectiveness ROA (TTM) 15.54%   ROE (TTM) 21.91%   ROIC (TTM) 21.96%	Growth Rate Diluted EPS Growth (TTM) 10.71%   Sales Growth (TTM) 0.45%   Profit Growth (TTM) 10.71%   Asset Growth (TTM) -7.58%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceuticals in Vietnam. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic – antipyretic; ear-nose-throat, cough, and asthma; ophthalmic – nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular – diabetic; supplemental alimentary;...